A prospective, randomized, double-blind, placebo-controlled Phase I/IIA Clinical Trial to demonstrate the safety and efficacy of DUOFAG® in bacterial infection treatment in patients with surgical wounds.
Latest Information Update: 22 Mar 2024
At a glance
- Drugs DUOFAG (Primary)
- Indications Bacterial infections; Pseudomonal infections; Staphylococcal infections; Surgical wound infections
- Focus Adverse reactions; First in man; Therapeutic Use
- Sponsors MB Pharma
Most Recent Events
- 18 Jan 2023 New trial record